MRPS18B
geneOn this page
Also known as MRPS18-2PTD017C6orf14HSPC183mS40
Summary
MRPS18B (mitochondrial ribosomal protein S18B, HGNC:14516) is a protein-coding gene on chromosome 6p21.33, encoding Small ribosomal subunit protein mS40 (Q9Y676). It is a selective cancer dependency (DepMap: 59.1% of cell lines).
Mammalian mitochondrial ribosomal proteins are encoded by nuclear genes and help in protein synthesis within the mitochondrion. Mitochondrial ribosomes (mitoribosomes) consist of a small 28S subunit and a large 39S subunit. They have an estimated 75% protein to rRNA composition compared to prokaryotic ribosomes, where this ratio is reversed. Another difference between mammalian mitoribosomes and prokaryotic ribosomes is that the latter contain a 5S rRNA. Among different species, the proteins comprising the mitoribosome differ greatly in sequence, and sometimes in biochemical properties, which prevents easy recognition by sequence homology. This gene encodes a 28S subunit protein that belongs to the ribosomal protein S18P family. The encoded protein is one of three that has significant sequence similarity to bacterial S18 proteins. The primary sequences of the three human mitochondrial S18 proteins are no more closely related to each other than they are to the prokaryotic S18 proteins. Pseudogenes corresponding to this gene are found on chromosomes 1q and 2q.
Source: NCBI Gene 28973 — RefSeq curated summary.
At a glance
- GWAS associations: 19
- Clinical variants (ClinVar): 61 total
- Druggable target: yes
- Cancer dependency (DepMap): dependent in 59.1% of screened cell lines
- MANE Select transcript:
NM_014046
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:14516 |
| Approved symbol | MRPS18B |
| Name | mitochondrial ribosomal protein S18B |
| Location | 6p21.33 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MRPS18-2, PTD017, C6orf14, HSPC183, mS40 |
| Ensembl gene | ENSG00000204568 |
| Ensembl biotype | protein_coding |
| OMIM | 611982 |
| Entrez | 28973 |
Gene structure
Transcript identifiers
Ensembl transcripts: 12 — 9 protein_coding, 2 retained_intron, 1 protein_coding_CDS_not_defined
ENST00000259873, ENST00000472229, ENST00000472267, ENST00000492316, ENST00000854951, ENST00000854952, ENST00000854953, ENST00000854954, ENST00000854955, ENST00000940251, ENST00000940252, ENST00000940253
RefSeq mRNA: 1 — MANE Select: NM_014046
NM_014046
CCDS: CCDS4682
Canonical transcript exons
ENST00000259873 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001633457 | 30617840 | 30617943 |
| ENSE00003481060 | 30624883 | 30624942 |
| ENSE00003559815 | 30625502 | 30626392 |
| ENSE00003568954 | 30619709 | 30619806 |
| ENSE00003577810 | 30619921 | 30619989 |
| ENSE00003599521 | 30619493 | 30619601 |
| ENSE00003653395 | 30622832 | 30622898 |
Expression profiles
Bgee: expression breadth ubiquitous, 140 present calls, max score 97.87.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 59.9405 / max 308.5750, expressed in 1821 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 66744 | 59.9405 | 1821 |
Top tissues by expression
141 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| gastrocnemius | UBERON:0001388 | 97.87 | gold quality |
| muscle of leg | UBERON:0001383 | 97.71 | gold quality |
| skeletal muscle organ | UBERON:0014892 | 97.69 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 97.30 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 97.20 | gold quality |
| heart left ventricle | UBERON:0002084 | 97.06 | gold quality |
| apex of heart | UBERON:0002098 | 96.96 | gold quality |
| muscle tissue | UBERON:0002385 | 96.38 | gold quality |
| islet of Langerhans | UBERON:0000006 | 96.05 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 95.89 | gold quality |
| rectum | UBERON:0001052 | 95.87 | gold quality |
| heart | UBERON:0000948 | 95.78 | gold quality |
| right adrenal gland | UBERON:0001233 | 95.68 | gold quality |
| body of pancreas | UBERON:0001150 | 95.51 | gold quality |
| pancreas | UBERON:0001264 | 95.46 | gold quality |
| right lobe of liver | UBERON:0001114 | 95.45 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 95.41 | gold quality |
| left adrenal gland | UBERON:0001234 | 95.20 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 95.19 | gold quality |
| right atrium auricular region | UBERON:0006631 | 95.03 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 94.92 | gold quality |
| liver | UBERON:0002107 | 94.74 | gold quality |
| duodenum | UBERON:0002114 | 94.71 | gold quality |
| fallopian tube | UBERON:0003889 | 94.51 | gold quality |
| body of stomach | UBERON:0001161 | 94.45 | gold quality |
| metanephros cortex | UBERON:0010533 | 94.41 | gold quality |
| adrenal gland | UBERON:0002369 | 94.32 | gold quality |
| kidney | UBERON:0002113 | 94.30 | gold quality |
| fundus of stomach | UBERON:0001160 | 94.24 | gold quality |
| cortex of kidney | UBERON:0001225 | 94.08 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-6386 | no | 567.13 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): CREB1, NCOR1, YY1
miRNA regulators (miRDB)
23 targeting MRPS18B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3617-3P | 99.98 | 67.86 | 918 |
| HSA-MIR-1236-3P | 99.94 | 68.04 | 1695 |
| HSA-MIR-338-5P | 99.92 | 72.34 | 2951 |
| HSA-MIR-6783-3P | 99.89 | 67.92 | 2059 |
| HSA-MIR-1343-3P | 99.89 | 66.78 | 1815 |
| HSA-MIR-6515-3P | 99.82 | 68.19 | 1933 |
| HSA-MIR-320A-3P | 99.77 | 69.73 | 2107 |
| HSA-MIR-320B | 99.77 | 69.73 | 2107 |
| HSA-MIR-320C | 99.77 | 69.73 | 2107 |
| HSA-MIR-320D | 99.77 | 69.73 | 2107 |
| HSA-MIR-4429 | 99.77 | 69.62 | 2111 |
| HSA-MIR-4524A-3P | 99.72 | 66.85 | 2406 |
| HSA-MIR-8077 | 99.17 | 66.67 | 862 |
| HSA-MIR-6506-5P | 99.04 | 65.66 | 1386 |
| HSA-MIR-4650-3P | 99.01 | 68.39 | 1062 |
| HSA-MIR-5701 | 98.97 | 69.54 | 1502 |
| HSA-MIR-619-5P | 98.57 | 64.97 | 1988 |
| HSA-MIR-6855-5P | 97.51 | 66.03 | 830 |
| HSA-MIR-500B-3P | 96.49 | 65.40 | 1087 |
| HSA-MIR-571 | 95.38 | 66.54 | 671 |
| HSA-MIR-3672 | 94.46 | 65.67 | 646 |
| HSA-MIR-6864-3P | 94.46 | 65.97 | 625 |
| HSA-MIR-4732-5P | 90.07 | 64.77 | 412 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 59.1% of screened cell lines.
Literature-anchored findings (GeneRIF, showing 8)
- EBNA-6 {ebna-3c} binds to MRPS18-2 , and targets it to the nucleus; binding targets the small pocket of pRb, which is a site of interaction with E2F1. The MRPS18-2 competes with the binding of E2F1 to pRb, thereby raising the level of free E2F1 (PMID:18391203)
- S18-2 is a newly identified oncoprotein that may be involved in cancerogenesis (PMID:26023799)
- We conclude that high expression of S18-2 and free E2F…1might be a good set of prognostic markers for endometrial cancer (PMID:26959119)
- Evolutionary trace analysis showed that the S18-2 protein is mutated at the higher rate in tumors, compared with S18-1 and S18-3. The one of the most conserved residues in the S18-2 protein sequence, Gly132, is often mutated in colorectal cancer. (PMID:27489352)
- Studies suggest that mitochondrial ribosomal protein S18-2 protein, together with the retinoblastoma protein (RB), plays a crucial role in the control on cell stemness and differentiation. (PMID:28361860)
- Together, these data suggest that the S18-2 protein induces epithelial to mesenchymal cell transition through the TWIST2/E-cadherin signalling and, consequently, CXCR4-mediated migration of prostate cancer cells. (PMID:29396484)
- trend for increasing expression of the S18-2 protein in tumors correlates with the aggressiveness of malignant breast cancer. (PMID:30593750)
- Expression pattern of MRPS18 family genes in gliomas. (PMID:34591434)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | mrps18b | ENSDARG00000007065 |
| mus_musculus | Mrps18b | ENSMUSG00000024436 |
| rattus_norvegicus | Mrps18b | ENSRNOG00000000804 |
| drosophila_melanogaster | mRpS18B | FBGN0032849 |
| caenorhabditis_elegans | WBGENE00011759 |
Protein
Protein identifiers
Small ribosomal subunit protein mS40 — Q9Y676 (reviewed: Q9Y676)
Alternative names: 28S ribosomal protein S18-2, mitochondrial, 28S ribosomal protein S18b, mitochondrial, Small ribosomal subunit protein bS18b
All UniProt accessions (2): B0S7P4, Q9Y676
UniProt curated annotations — full annotation on UniProt →
Subunit / interactions. Component of the mitochondrial small ribosomal subunit (mt-SSU). Mature mammalian 55S mitochondrial ribosomes consist of a small (28S) and a large (39S) subunit. The 28S small subunit contains a 12S ribosomal RNA (12S mt-rRNA) and 30 different proteins. The 39S large subunit contains a 16S rRNA (16S mt-rRNA), a copy of mitochondrial valine transfer RNA (mt-tRNA(Val)), which plays an integral structural role, and 52 different proteins. mS40 has a zinc binding site.
Subcellular location. Mitochondrion.
Miscellaneous. There are 3 mitochondrial isoforms of bS18 in mammalia, localizing to 3 distinct sites in the mitoribosome. bS18m (bs18c) binds to the same site as bacterial bS18, mS40 (bS18b, this protein) binds to a novel location of the 28S small subunit, and mL66 (bS18a) binds to the 39S large subunit.
Similarity. Belongs to the bacterial ribosomal protein bS18 family. Mitochondrion-specific ribosomal protein mS40 subfamily.
RefSeq proteins (1): NP_054765* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001648 | Ribosomal_bS18 | Family |
| IPR036870 | Ribosomal_bS18_sf | Homologous_superfamily |
| IPR040054 | MRPS18B | Family |
Pfam: PF01084
UniProt features (25 total): helix 8, turn 5, strand 3, compositionally biased region 2, modified residue 2, transit peptide 1, chain 1, region of interest 1, sequence variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
76 structures, top 30 by resolution.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 7QI4 | ELECTRON MICROSCOPY | 2.21 |
| 8CSS | ELECTRON MICROSCOPY | 2.36 |
| 7P2E | ELECTRON MICROSCOPY | 2.4 |
| 8RRI | ELECTRON MICROSCOPY | 2.4 |
| 9OLF | ELECTRON MICROSCOPY | 2.46 |
| 8CSQ | ELECTRON MICROSCOPY | 2.54 |
| 8CSR | ELECTRON MICROSCOPY | 2.54 |
| 6ZM6 | ELECTRON MICROSCOPY | 2.59 |
| 7QI5 | ELECTRON MICROSCOPY | 2.63 |
| 8CSP | ELECTRON MICROSCOPY | 2.66 |
| 7PNX | ELECTRON MICROSCOPY | 2.76 |
| 8ANY | ELECTRON MICROSCOPY | 2.85 |
| 8CST | ELECTRON MICROSCOPY | 2.85 |
| 6ZM5 | ELECTRON MICROSCOPY | 2.89 |
| 7PO0 | ELECTRON MICROSCOPY | 2.9 |
| 8K2A | ELECTRON MICROSCOPY | 2.9 |
| 9PGL | ELECTRON MICROSCOPY | 2.9 |
| 7PO1 | ELECTRON MICROSCOPY | 2.92 |
| 7PO3 | ELECTRON MICROSCOPY | 2.92 |
| 9PGF | ELECTRON MICROSCOPY | 2.93 |
| 6VMI | ELECTRON MICROSCOPY | 2.96 |
| 6RW4 | ELECTRON MICROSCOPY | 2.97 |
| 6VLZ | ELECTRON MICROSCOPY | 2.97 |
| 7QI6 | ELECTRON MICROSCOPY | 2.98 |
| 8QRN | ELECTRON MICROSCOPY | 2.98 |
| 9PSM | ELECTRON MICROSCOPY | 2.98 |
| 8OIS | ELECTRON MICROSCOPY | 3 |
| 9G5C | ELECTRON MICROSCOPY | 3 |
| 9G5D | ELECTRON MICROSCOPY | 3 |
| 9HFM | ELECTRON MICROSCOPY | 3 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9Y676-F1 | 83.25 | 0.69 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 38, 49
Function
Pathways and Gene Ontology
Reactome pathways
7 pathways
| ID | Pathway |
|---|---|
| R-HSA-5368286 | Mitochondrial translation initiation |
| R-HSA-5389840 | Mitochondrial translation elongation |
| R-HSA-5419276 | Mitochondrial translation termination |
| R-HSA-9937383 | Mitochondrial ribosome-associated quality control |
| R-HSA-392499 | Metabolism of proteins |
| R-HSA-5368287 | Mitochondrial translation |
| R-HSA-72766 | Translation |
MSigDB gene sets: 266 (showing top):
MORF_MTA1, RNGTGGGC_UNKNOWN, FXR_IR1_Q6, SHEPARD_BMYB_MORPHOLINO_UP, YAGI_AML_WITH_INV_16_TRANSLOCATION, TGCGCANK_UNKNOWN, MORF_BUB1, MODULE_151, SHEPARD_CRASH_AND_BURN_MUTANT_UP, GOBP_MITOCHONDRIAL_TRANSLATION, CREBP1_Q2, MORF_HDAC2, GOBP_TRANSLATION, IRF7_01, FREAC3_01
GO Biological Process (2): translation (GO:0006412), mitochondrial translation (GO:0032543)
GO Molecular Function (2): structural constituent of ribosome (GO:0003735), protein binding (GO:0005515)
GO Cellular Component (7): nucleoplasm (GO:0005654), mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), mitochondrial small ribosomal subunit (GO:0005763), cell junction (GO:0030054), ribosome (GO:0005840), ribonucleoprotein complex (GO:1990904)
Reactome top-level categories
Rollup of top-3 pathways:
| Category | Pathways |
|---|---|
| Mitochondrial translation | 4 |
| Translation | 1 |
| Metabolism of proteins | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| peptidyltransferase activity | 1 |
| translational initiation | 1 |
| translational elongation | 1 |
| translational termination | 1 |
| macromolecule biosynthetic process | 1 |
| protein metabolic process | 1 |
| protein biosynthetic process | 1 |
| mitochondrion | 1 |
| translation | 1 |
| mitochondrial gene expression | 1 |
| structural molecule activity | 1 |
| ribosome | 1 |
| binding | 1 |
| nuclear lumen | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle inner membrane | 1 |
| mitochondrial membrane | 1 |
| organellar small ribosomal subunit | 1 |
| mitochondrial ribosome | 1 |
| mitochondrial protein-containing complex | 1 |
| intracellular membraneless organelle | 1 |
| protein-containing complex | 1 |
Protein interactions and networks
STRING
1392 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MRPS18B | MRPS18A | Q9NVS2 | 986 |
| MRPS18B | MRPL12 | P52815 | 753 |
| MRPS18B | DAP3 | P51398 | 742 |
| MRPS18B | MRPS7 | Q9Y2R9 | 720 |
| MRPS18B | MRPL11 | Q9Y3B7 | 671 |
| MRPS18B | MRPS33 | Q9Y291 | 666 |
| MRPS18B | MRPS22 | P82650 | 664 |
| MRPS18B | ERAL1 | O75616 | 655 |
| MRPS18B | MRPL45 | Q9BRJ2 | 648 |
| MRPS18B | MRPS27 | Q92552 | 605 |
| MRPS18B | MRPL37 | Q9BZE1 | 597 |
| MRPS18B | MPV17L2 | Q567V2 | 561 |
| MRPS18B | MRPL48 | Q96GC5 | 558 |
| MRPS18B | MRPS18C | Q9Y3D5 | 545 |
| MRPS18B | MRPL58 | Q14197 | 544 |
IntAct
223 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| FBL | NOP56 | psi-mi:“MI:0914”(association) | 0.800 |
| MRPS18B | MRPS27 | psi-mi:“MI:0915”(physical association) | 0.770 |
| MRPS18B | EBNA6 | psi-mi:“MI:0914”(association) | 0.660 |
| EBNA6 | MRPS18B | psi-mi:“MI:0407”(direct interaction) | 0.660 |
| MRPS18B | EBNA6 | psi-mi:“MI:0915”(physical association) | 0.660 |
| MRPS18B | EBNA6 | psi-mi:“MI:0407”(direct interaction) | 0.660 |
| MRPS27 | MRPS14 | psi-mi:“MI:0914”(association) | 0.640 |
| LIN28A | IGF2BP3 | psi-mi:“MI:0914”(association) | 0.640 |
| MRPS18B | MRPS22 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM120B | MRPS18B | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMED8 | MRPS18B | psi-mi:“MI:0915”(physical association) | 0.560 |
| LRP10 | MRPS18B | psi-mi:“MI:0915”(physical association) | 0.560 |
| SYS1 | MRPS18B | psi-mi:“MI:0915”(physical association) | 0.560 |
| SLC35A1 | MRPS18B | psi-mi:“MI:0915”(physical association) | 0.560 |
| BMP10 | MRPS18B | psi-mi:“MI:0915”(physical association) | 0.560 |
| LAT | MRPS18B | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZFPL1 | MRPS18B | psi-mi:“MI:0915”(physical association) | 0.560 |
| TUSC5 | MRPS18B | psi-mi:“MI:0915”(physical association) | 0.560 |
| MIP | MRPS18B | psi-mi:“MI:0915”(physical association) | 0.560 |
| CD81 | MRPS18B | psi-mi:“MI:0915”(physical association) | 0.560 |
| CLEC1A | MRPS18B | psi-mi:“MI:0915”(physical association) | 0.560 |
| TNFRSF10C | MRPS18B | psi-mi:“MI:0915”(physical association) | 0.560 |
| SEC22B | MRPS18B | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM128 | MRPS18B | psi-mi:“MI:0915”(physical association) | 0.560 |
| IGFBP5 | MRPS18B | psi-mi:“MI:0915”(physical association) | 0.560 |
| NP | KPNA6 | psi-mi:“MI:0914”(association) | 0.550 |
| RPS6 | IPO7 | psi-mi:“MI:0914”(association) | 0.530 |
| TRMT10B | MRPS14 | psi-mi:“MI:0914”(association) | 0.530 |
BioGRID (391): MRPS18B (Affinity Capture-RNA), MRPS18B (Affinity Capture-MS), MRPS18B (Affinity Capture-MS), MRPS18B (Affinity Capture-MS), MRPS18B (Two-hybrid), MRPS18B (Affinity Capture-MS), MRPS18B (Co-fractionation), MRPS18B (Co-fractionation), MRPS18B (Co-fractionation), MRPS18B (Co-fractionation), MRPS18B (Co-fractionation), MRPS18B (Co-fractionation), MRPS6 (Co-fractionation), MRPS18B (Affinity Capture-MS), MRPS18B (Affinity Capture-MS)
ESM2 similar proteins: P0C2B8, P0C2C1, P49406, P82675, P82913, P82933, Q13084, Q1XHY1, Q29IK4, Q2HJI0, Q2HJJ1, Q2KID9, Q2TBI6, Q3T040, Q3T0J3, Q3ZBR7, Q498Z6, Q4R6U7, Q58DQ5, Q58DV5, Q5I0K8, Q5M818, Q5R7L3, Q5R8M4, Q5REJ1, Q5SPH9, Q5TM62, Q5ZMU0, Q68EV6, Q6DDY9, Q6DGL8, Q80X85, Q8TCC3, Q99N85, Q99N87, Q99N93, Q9BYC8, Q9CQL5, Q9D1B9, Q9D338
Diamond homologs: A0AEM3, A0LAG7, A0LN58, A4ITV8, A5G7R2, A5IJG9, A5UYQ5, A6LKQ1, A7GVN5, A8FJE5, A8ZRQ2, A9BH64, B1L8K5, B5EHW8, B5Y876, B8DAM0, B9M5U9, C0R3A3, C1F903, C1KV87, C5D9X4, C6E504, P10806, P21475, P66461, P66462, P82917, P82918, Q01QR5, Q0RTD6, Q1IHW4, Q1XHY1, Q2G8G4, Q3AG25, Q4A5M9, Q5GSD5, Q5KU71, Q5TM62, Q5WAH5, Q65CP5
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| MRPS18B | “form complex” | “28S mitochondrial small ribosomal subunit” | binding |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 194 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Mitochondrial translation | 17 | 18.3× | 4e-15 |
| Mitochondrial translation initiation | 18 | 17.8× | 1e-15 |
| Mitochondrial translation elongation | 18 | 17.8× | 1e-15 |
| Mitochondrial ribosome-associated quality control | 18 | 17.3× | 2e-15 |
| Mitochondrial translation termination | 18 | 15.4× | 8e-15 |
| Translation | 21 | 10.2× | 1e-13 |
| Mitochondrial protein degradation | 7 | 6.2× | 1e-02 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| mitochondrial translation | 17 | 17.2× | 1e-13 |
| ribosomal small subunit biogenesis | 7 | 9.3× | 4e-03 |
| translation | 13 | 7.8× | 8e-06 |
| protein import into nucleus | 8 | 6.7× | 8e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
61 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 39 |
| Likely benign | 7 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
532 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 6:30619488:TGTAG:T | acceptor_gain | 1.0000 |
| 6:30619489:GTA:G | acceptor_loss | 1.0000 |
| 6:30619489:GTAGG:G | acceptor_gain | 1.0000 |
| 6:30619490:TAGGT:T | acceptor_gain | 1.0000 |
| 6:30619491:A:AG | acceptor_gain | 1.0000 |
| 6:30619491:AG:A | acceptor_gain | 1.0000 |
| 6:30619492:G:GG | acceptor_gain | 1.0000 |
| 6:30619492:GG:G | acceptor_gain | 1.0000 |
| 6:30619492:GGT:G | acceptor_gain | 1.0000 |
| 6:30619492:GGTT:G | acceptor_gain | 1.0000 |
| 6:30619492:GGTTC:G | acceptor_gain | 1.0000 |
| 6:30619597:AGAAG:A | donor_loss | 1.0000 |
| 6:30619598:GAAG:G | donor_gain | 1.0000 |
| 6:30619599:A:T | donor_gain | 1.0000 |
| 6:30619599:AAGG:A | donor_loss | 1.0000 |
| 6:30619600:AGGT:A | donor_loss | 1.0000 |
| 6:30619601:GGT:G | donor_loss | 1.0000 |
| 6:30619602:GT:G | donor_loss | 1.0000 |
| 6:30619603:T:G | donor_loss | 1.0000 |
| 6:30619702:A:AG | acceptor_gain | 1.0000 |
| 6:30619703:T:G | acceptor_gain | 1.0000 |
| 6:30619706:CA:C | acceptor_loss | 1.0000 |
| 6:30619707:A:AG | acceptor_gain | 1.0000 |
| 6:30619708:G:GA | acceptor_gain | 1.0000 |
| 6:30619708:GA:G | acceptor_gain | 1.0000 |
| 6:30619708:GAA:G | acceptor_gain | 1.0000 |
| 6:30619708:GAAT:G | acceptor_gain | 1.0000 |
| 6:30619708:GAATA:G | acceptor_gain | 1.0000 |
| 6:30619794:G:GT | donor_gain | 1.0000 |
| 6:30619797:GACAT:G | donor_gain | 1.0000 |
AlphaMissense
1654 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 6:30622853:T:C | F126L | 0.995 |
| 6:30622855:T:A | F126L | 0.995 |
| 6:30622855:T:G | F126L | 0.995 |
| 6:30619741:T:A | W74R | 0.988 |
| 6:30619741:T:C | W74R | 0.988 |
| 6:30624910:T:C | L150S | 0.985 |
| 6:30624930:G:C | A157P | 0.985 |
| 6:30619743:G:C | W74C | 0.983 |
| 6:30619743:G:T | W74C | 0.983 |
| 6:30622854:T:C | F126S | 0.982 |
| 6:30619739:T:A | V73D | 0.981 |
| 6:30624918:G:C | A153P | 0.980 |
| 6:30619948:T:C | C105R | 0.979 |
| 6:30622834:C:A | N119K | 0.978 |
| 6:30622834:C:G | N119K | 0.978 |
| 6:30624931:C:A | A157D | 0.975 |
| 6:30622854:T:G | F126C | 0.974 |
| 6:30619586:T:C | Y58H | 0.972 |
| 6:30619973:T:C | L113S | 0.972 |
| 6:30619756:C:A | R79S | 0.968 |
| 6:30622845:T:C | L123S | 0.967 |
| 6:30619957:T:A | C108S | 0.966 |
| 6:30619958:G:C | C108S | 0.966 |
| 6:30624888:T:C | C143R | 0.966 |
| 6:30619711:T:G | Y64D | 0.964 |
| 6:30619961:G:C | R109P | 0.963 |
| 6:30619587:A:C | Y58S | 0.961 |
| 6:30619595:T:C | S61P | 0.961 |
| 6:30619712:A:C | Y64S | 0.961 |
| 6:30619587:A:G | Y58C | 0.960 |
dbSNP variants (sampled 300 via entrez): RS1000048094 (6:30626582 C>T), RS1000442325 (6:30616660 C>A,T), RS1000473154 (6:30616508 G>A), RS1000655568 (6:30621065 C>A,T), RS1000967267 (6:30617785 G>C,T), RS1001627477 (6:30626171 A>C,G,T), RS1001683130 (6:30620044 G>A), RS1001814458 (6:30624216 C>G), RS1001819995 (6:30620368 G>A), RS1002067532 (6:30619090 G>A,C,T), RS1002088324 (6:30622230 A>T), RS1002416888 (6:30618809 C>T), RS1002572184 (6:30621968 T>C), RS1002757562 (6:30619463 A>G), RS1002830051 (6:30619221 C>G)
Disease associations
OMIM: gene MIM:611982 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
19 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004521_114 | Autism spectrum disorder or schizophrenia | 3.000000e-17 |
| GCST004521_117 | Autism spectrum disorder or schizophrenia | 3.000000e-15 |
| GCST004521_121 | Autism spectrum disorder or schizophrenia | 3.000000e-13 |
| GCST004521_132 | Autism spectrum disorder or schizophrenia | 2.000000e-09 |
| GCST004521_171 | Autism spectrum disorder or schizophrenia | 4.000000e-14 |
| GCST004521_2 | Autism spectrum disorder or schizophrenia | 2.000000e-16 |
| GCST004521_209 | Autism spectrum disorder or schizophrenia | 5.000000e-16 |
| GCST004521_210 | Autism spectrum disorder or schizophrenia | 5.000000e-15 |
| GCST004521_211 | Autism spectrum disorder or schizophrenia | 5.000000e-15 |
| GCST004521_263 | Autism spectrum disorder or schizophrenia | 7.000000e-17 |
| GCST004521_265 | Autism spectrum disorder or schizophrenia | 7.000000e-14 |
| GCST004521_269 | Autism spectrum disorder or schizophrenia | 7.000000e-11 |
| GCST004521_295 | Autism spectrum disorder or schizophrenia | 6.000000e-18 |
| GCST004521_3 | Autism spectrum disorder or schizophrenia | 2.000000e-15 |
| GCST004521_56 | Autism spectrum disorder or schizophrenia | 1.000000e-22 |
| GCST004521_70 | Autism spectrum disorder or schizophrenia | 8.000000e-20 |
| GCST004521_79 | Autism spectrum disorder or schizophrenia | 1.000000e-16 |
| GCST008161_15 | Waist circumference adjusted for body mass index | 5.000000e-06 |
| GCST011053_2 | Neuroblastoma (pediatric) | 4.000000e-18 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007789 | BMI-adjusted waist circumference |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL6067441 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
35 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Acetaminophen | affects cotreatment, decreases expression | 3 |
| bisphenol F | increases expression, affects cotreatment | 2 |
| sodium arsenite | decreases expression, increases expression | 2 |
| Tunicamycin | increases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| FR900359 | increases phosphorylation | 1 |
| triphenyl phosphate | affects expression | 1 |
| deoxynivalenol | increases expression | 1 |
| trichostatin A | affects expression | 1 |
| potassium chromate(VI) | increases expression | 1 |
| nickel sulfate | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| chromium hexavalent ion | decreases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| bisphenol B | increases expression | 1 |
| LDN 193189 | affects cotreatment, decreases expression | 1 |
| bisphenol AF | increases expression | 1 |
| Temozolomide | increases expression | 1 |
| Atrazine | decreases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Dexamethasone | increases expression, affects cotreatment | 1 |
| Doxorubicin | decreases expression | 1 |
| Indomethacin | affects cotreatment, increases expression | 1 |
| Ivermectin | decreases expression | 1 |
| Lipopolysaccharides | affects cotreatment, decreases expression | 1 |
| Mustard Gas | increases expression | 1 |
| Ribonucleotides | affects binding | 1 |
| Dronabinol | decreases expression | 1 |
| Thiram | decreases expression | 1 |
| 1-Methyl-3-isobutylxanthine | affects cotreatment, increases expression | 1 |
ChEMBL screening assays
1 unique, capped per target: 1 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL5652929 | Binding | Binding affinity to human MRPS18B incubated for 45 mins by Kinobead based pull down assay | NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family. — ChemMedChem |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): neuroblastoma